Why is Saroja Pharma In falling/rising?

As of 12-Sep, Saroja Pharma Industries India Ltd is experiencing a decline in its stock price, currently at 47.05, which reflects a decrease of 2.2 or 4.47%. The stock has underperformed its sector by 4.76% today, despite showing a higher performance compared to its 50-day, 100-day, and 200-day moving averages. However, it is lower than the 5-day and 20-day moving averages. Notably, there has been a significant increase in investor participation, with delivery volume rising by 87.5% against the 5-day average. The stock's performance over the past week shows a decline of 9.08%, while it has increased by 27.68% over the past month. Year-to-date, the stock is down 21.58%, and over the past year, it has decreased by 18.88%.
In the broader market context, the Sensex has shown a positive return of 1.51% over the past week and 2.56% over the past month, indicating that the overall market is performing well compared to Saroja Pharma's recent struggles. The stock's year-to-date performance is significantly lagging behind the Sensex, which has gained 6.21% during the same period. This disparity suggests that while the market is experiencing growth, Saroja Pharma is facing challenges that are contributing to its declining stock price. The absence of specific positive or negative dashboard factors limits the analysis of the underlying reasons for the stock's movement, but the overall underperformance relative to the benchmark indicates a lack of investor confidence in the company's prospects at this time.